Psilocybin capsules 15 mg, Psilocybin capsules 25 mg, Psilocybin capsules 1 mg
18870
Phase 2 small_molecule active
Quick answer
Psilocybin capsules 15 mg, Psilocybin capsules 25 mg, Psilocybin capsules 1 mg for Chronic obstructive pulmonary disease (COPD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and atypical Parkinson disorder (APD), particularly multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS). is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Chronic obstructive pulmonary disease (COPD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and atypical Parkinson disorder (APD), particularly multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS).
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active